Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery

• Conditions: Postpartum Infectious Morbidity in Cesarean Section Delivery

• Registration Number: NCT03007706
• Lead Sponsor: Raghda Gamal Mohamed

Brief Summary

This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.

Detailed Description

Not available

Study Timeline

• Status Verified: 2016-12
• Study First Submitted: 2016-12-29
• Study First Submitted QC: 2016-12-29
• Last Update Submitted: 2016-12-30
• Study Start: 2017-01
• Study First Posted: 2017-01-02
• Last Update Posted: 2017-01-04
• Primary Completion: 2017-06
• Study Completion: 2017-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

1. Women undergoing cesarean delivery, both elective and non-elective.
2. Rupture of membranes and labor contractions will be allowed.

Exclusion Criteria

1. Unknown outcome from the patient.
2. Refusing to participate in the study from the admission conse
3. Allergy to antibiotics.
4. Any visible infection.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
role of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity	2 weeks following cesarean section